HCM FY 2019 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

FY 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$205M-4.3% YoY

Gross Profit

$45M21.8% margin

Operating Income

-$145M-70.8% margin

Net Income

-$104M-50.6% margin

EPS (Diluted)

$-1.10

Cash Flow

Operating Cash Flow

-$81M

Free Cash Flow

-$89M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$465M

Total Liabilities

$152M

Stockholders' Equity

$288M

Cash & Equivalents

$121M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$205M	$214M	-4.3%
Gross Profit	$45M	$70M	-36.2%
Operating Income	-$145M	-$93M	-56.5%
Net Income	-$104M	-$75M	-38.6%